The shares lifted 5% to 11,920p, valuing AstraZeneca at £183 billion, only £1 billion less than London’s biggest listed firm ...

AstraZeneca’s chief executive Pascal Soriot is “massively underpaid” and deserves a proposed £1.8mn pay rise, according to ...

The pharmaceutical giant said it would increase its annual dividend payout by 20 cents to $3.10 dollars (£2.47) per share for ...

AstraZeneca's sales of cancer drugs helped the pharmaceutical firm beat first-quarter estimates for earnings and revenue.

The British drugmaker has bolstered its business with nearly $5 billion in acquisitions as attention turns to its pipeline of experimental medicines.

Inevitably, all the fingers were pointed at AstraZeneca's Pascal Soriot, considered the main culprit. "How is it possible ...

In early corporate news, miner Anglo American confirmed Thursday it was "reviewing" a takeover bid from its larger Australian rival BHP Group, in what would rank as one of the sector's biggest deals ...

The European Central Bank held interest rates at all-time highs on Thursday but kept the door open to cuts at its next ...